CompoAtlas

Glucosamine, chondroitine et harpagophytum

Food supplement declared in France, declaration No 2021-6-610, decision dated 10 June 2021

Glucosamine, chondroitine et harpagophytum (Boticinal laboratoire) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Harpagophytum procumbens 160 mg per day, Vitamin C, Chlorhydrate de glucosamine, Sulfate de chondroïtine. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Boticinal laboratoire
Food business operator placing the product on the market
BOTICINAL
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
4 gélules par jour
Directions for use
A avaler avec un grand verre d'eau au milieu des repas.
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Pregnant women, Kidney failure, Kidney disease, Taking diabetes medication, Ulcer (stomach or duodenum)
Objectives stated by the manufacturer (these are not authorised claims)
Joints

Declaration 225647, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Harpagophytum procumbensRootDry hydroalcoholic extract160 mg

Other active ingredients

NamePer day
Chlorhydrate de glucosaminenot declared
Sulfate de chondroïtinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
L-ascorbic acidVitamin Cno limit (insufficient data)180 mg

Other ingredients

Gélule végétale

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Déconseillé en cas d'ulcères (estomac ou duodenum) ou de calculs biliaires. Déconseillé en cas de troubles rénaux ainsi qu'aux personnes diabétiques ou pré-diabétiques, asthmatiques ou traitées par antivitamine K, aux personnes dont l'alimentation est contrôlée pour le sodium, le potassium ou le calcium ainsi qu'aux femmes enceintes ou allaitantes et aux enfants.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Harpagophytum procumbens
    Read the warning, when it applies and the studies cited

    DEVIL'S CLAW - HARPAGOPHYTUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Boticinal laboratoire

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Glucosamine, chondroitine et harpagophytum (Boticinal laboratoire): composition and regulation”, https://compoatlas.com/en/supplements/products/225647-glucosamine-chondroitine-et-harpagophytum, updated 15 November 2026.

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line